tirzepatide news october 18 2025 Semaglutide and treatment leads to weight loss in type 1 diabetes Drugmakers battle pharmacies over compounded

Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P

Major GLP-1 trials including SUSTAIN and STEP studies reported hypoglycemia rates of 28% in Type 2 diabetes patients on semaglutide monotherapy, compared to 2040% in those on insulin

Cardiovascular Health Supports Heart Health : Vitamin D helps maintain healthy blood pressure and supports overall cardiovascular health, reducing the risk of heart disease

Allergic Reactions : Symptoms include swelling of the face, tongue, or throat, difficulty breathing, hives, and severe rash

Real-world data from Mounjaro prescription refill patterns shows approximately 70% of patients continue treatment at 12 months, substantially higher than adherence rates for most chronic disease medications